Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 25.98
-0.49 (-1.85%)
At close: Sep 2, 2026
SHE:301258 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 6.6 | 64.29 | 16.41 | 112.18 | 177.31 | 120.2 |
Depreciation & Amortization | 48.09 | 47.57 | 49.05 | 56.64 | 51.87 | 46.11 |
Other Amortization | 1.71 | 1.71 | 1.27 | 0.74 | - | - |
Loss (Gain) From Sale of Assets | 0.22 | 0.3 | 0.93 | 0.39 | - | - |
Asset Writedown & Restructuring Costs | 52.23 | 1.66 | 14.36 | 2.64 | 5.92 | 4.25 |
Loss (Gain) From Sale of Investments | -86.88 | -78.52 | -29.44 | -24.97 | -2.82 | -4.24 |
Provision & Write-off of Bad Debts | -1.54 | -1.54 | 1.51 | - | - | - |
Other Operating Activities | 9.57 | 1.85 | 0.11 | -2.68 | -24.7 | 3.11 |
Change in Accounts Receivable | -35.06 | 3.44 | -42.52 | 11.21 | -37.96 | -12.9 |
Change in Inventory | -8.6 | 24.81 | -0.61 | -34.24 | -57.81 | -11.22 |
Change in Accounts Payable | 8.02 | -3.98 | 39.89 | -27.35 | 27.34 | 49.22 |
Change in Other Net Operating Assets | - | - | - | - | 7.11 | 3.27 |
Operating Cash Flow | -8.83 | 66.6 | 47.07 | 94.77 | 151.19 | 199.73 |
Operating Cash Flow Growth | - | 41.50% | -50.33% | -37.32% | -24.30% | 19.71% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -149.16 | -146.5 | -105.31 | -41.62 | -50.11 | -80.75 |
Sale of Property, Plant & Equipment | -4.04 | 0.75 | 8.83 | 0.07 | 0.19 | 0.15 |
Investment in Securities | 371.75 | 275.57 | -42.61 | 69.26 | -1,138 | 100 |
Other Investing Activities | 41.05 | 32 | 39.97 | 20.86 | 13.79 | 10.71 |
Investing Cash Flow | 259.6 | 161.82 | -99.12 | 48.56 | -1,174 | 30.12 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | - | - | - | - | 18.56 |
Total Debt Issued | - | - | - | - | - | 18.56 |
Short-Term Debt Repaid | - | - | - | - | -18.56 | - |
Long-Term Debt Repaid | - | -0.76 | -0.71 | -0.71 | -0.48 | - |
Total Debt Repaid | -0.76 | -0.76 | -0.71 | -0.71 | -19.04 | - |
Net Debt Issued (Repaid) | -0.76 | -0.76 | -0.71 | -0.71 | -19.04 | 18.56 |
Issuance of Common Stock | - | - | - | - | 1,024 | - |
Repurchase of Common Stock | -78.37 | -78.37 | -20.14 | - | - | - |
Common Dividends Paid | -19.49 | -8.26 | -54.98 | -53.17 | -36.93 | -0.44 |
Dividends Paid | -19.49 | -8.26 | -54.98 | -53.17 | -36.93 | -0.44 |
Other Financing Activities | 0.84 | - | - | - | -25.25 | - |
Financing Cash Flow | -97.78 | -87.39 | -75.83 | -53.88 | 942.79 | 18.13 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -11.81 | -4.08 | 2.87 | 0.6 | 27.23 | -4.65 |
Net Cash Flow | 141.19 | 136.96 | -125.01 | 90.05 | -52.93 | 243.33 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -157.98 | -79.9 | -58.25 | 53.15 | 101.08 | 118.98 |
Free Cash Flow Growth | - | - | - | -47.42% | -15.05% | 17.62% |
Free Cash Flow Margin | -40.07% | -18.46% | -13.56% | 10.86% | 17.79% | 22.81% |
Free Cash Flow Per Share | -1.77 | -0.88 | -0.64 | 0.58 | 1.17 | 1.73 |
Levered Free Cash Flow | -170.12 | -34.65 | -61.95 | 35.51 | 29.37 | 86.31 |
Unlevered Free Cash Flow | -170.08 | -34.61 | -61.9 | 35.58 | 29.56 | 86.59 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 0.31 | 20.52 | 1.25 | 17.95 | 7.95 | -9.3 |
Change in Working Capital | -38.83 | 29.28 | -7.11 | -50.18 | -56.39 | 30.31 |